JANUARY IS SUBSTANCE USE DISORDER TREATMENT MONTH

Click here for free resources

This week we feature stories on the use of psilocybin to treat binge eating disorder, a new Colorado law which equalizes insurance coverage for behavioral and physical health, and the case for raising doses of buprenorphine.

In our research section, a variety of papers are featured, including ones on the difficulty of treating fentanyl users with buprenorphine, a surprising link between psoriasis and addiction and more.   

HEADLINES



Psilocybin therapy shows promise for binge eating disorder

Colorado law equalizes insurance coverage for behavioral, physical health

The case for higher-dose buprenorphine

High Standards: Marijuana reclassification and NRC fitness-for-duty requirements

NEW PAPERS AND REPORTS

Barriers to Buprenorphine Initiation in Patients Using Fentanyl (JAMA Open Network. January 6, 2025)

New Study Reveals High Rates of Addiction Among Patients with Psoriasis and Other Conditions (Dermatology Times. January 6, 2025)

DEA CY 2024 Methamphetamine Report (Drug Enforcement Administration, January 5, 2025)

Fentanyl’s Deadly Footprint: A New Framework for Predicting Overdose Hotspots (Cureus. January 6, 2025)

Find more research here